ABSTRACT: HIV-1 envelope glycoprotein-mediated fusion is driven by the concerted coalescence of the HIV-1 gp41 N-and C-helical regions, which results in the formation of 6-helix bundles. These two regions are considered prime targets for peptides and antibodies that inhibit HIV-1 entry. However, the parameters that govern this inhibition have yet to be elucidated. We address this issue by monitoring the temporal sequence of conformational states of HIV-1 gp41 during the course of HIV-1-mediated cell-cell fusion by quantitative video microscopy using reagents that bind to N-and C-helical regions, respectively. Envexpressing cells were primed by incubation with target cells at different times at 37°C followed by washing. The reactivity of triggered gp41 to the NC-1 monoclonal antibody, which we demonstrate here to bind to N-helical gp41 trimers, increased rapidly to a maximal level in the primed state but decreased once stable fusion junctions had formed. In contrast, reactivity with 5-helix, which binds to the C-helical region of gp41, increased continuously as a function of time following the priming. The peptide N36 Mut(e,g) reduced NC-1 monoclonal antibody binding and enhanced 5-helix binding, consistent with the notion that this molecule promotes dissociation of gp41 trimers. This inactivation pathway may be important for the design of entry inhibitors and vaccine candidates.
Membrane fusion mediated by human immunodeficiency virus (HIV)-1 1 envelope glycoproteins (gp120-gp41) is a critical step in the entry of the virus into susceptible cells (1) . The current model of HIV viral entry involves the binding of the trimeric viral envelope glycoprotein gp120/ gp41 to cell-surface receptor CD4 and chemokine coreceptor CXCR4 or CCR5 (2, 3) , which triggers conformational changes in the envelope proteins (4) . gp120 then disengages from gp41, allowing for the fusion peptide to be inserted into the target membrane and the prehairpin configuration of the ectodomain to form (5-7). The C-terminal heptad repeat region (C-helical region) and the leucine/isoleucine zipper region (N-helical region) 2 then form the thermostable 6-helix bundle (8) (9) (10) (11) , which drives the membrane merger and eventual fusion (12) . In addition to structural information, a wealth of HIV Env-mediated fusion data, which includes inhibition by peptides that mimic the sequences of the Nand C-helical regions (13) (14) (15) (16) (17) (18) (19) (20) (21) and fusion kinetics (22) , has lent credence to this model. In the absence of complete structural information, some of the details of the HIV-1 Envmediated fusion reaction have been inferred from immunochemical, biochemical, and mutagenic analysis. However, conclusions reached from these studies are controversial with regard to the timing and nature of conformational changes in HIV-1 gp41 that lead to fusion.
A number of regions of HIV-1 gp41 have been found to be particularly immunogenic in ViVo. One of these regions spans amino acid residues 598-604 (cluster I) and includes a nonhelical hydrophilic region that forms a disulfide loop in the 6-helix bundle (23) . The other region (cluster II) includes residues 644-663 and comprises a portion of the C-helix. In the absence of triggering by HIV receptors, antibodies to these epitope clusters react minimally with HIV-1 Env. After the interaction with sCD4 or cell surfacebound CD4, a substantial increase in immunoreactivity to these antibodies is observed, probably reflecting conformational changes in gp41 (24) . The increased reactivity has been observed in the absence of gp120 dissociation (25) , indicating that subunit dissociation is not absolutely required for these CD4-induced conformational changes to occur. ity of HIV-1 Env primed by sCD4 or cell-surface-bound CD4 (6, 12, 22, 26) to N-or C-helical region peptides leads to the hypothesis that the immunoreactive gp41 antigen is reflecting exposure of the gp41 prehairpin fusion intermediate. While there seems to be general concurrence on the CD4-triggered conformational changes in gp41 that lead to the appearance of prehairpin conformations prior to the fusion event, there is disagreement regarding the formation of the 6-helix bundle relative to fusion.
According to Weiss and colleagues, CD4 is sufficient for triggering Env into the 6-helix bundle (27) . This proposition was supported by the observation that the presumed anti-6-helix bundle MAb, NC-1, and rabbit sera raised against 6-helix bundle react with CD4-triggered HIV-1 gp41 (28) . If CD4 is sufficient to trigger 6-helix bundle formation, the question arises as to why coreceptors are required for the fusion event. It has been suggested that the coreceptors function by facilitating other events in the fusion process (6). Golding and co-workers (29) proposed that the 6-helix bundles help bring the cellular and viral membranes in close proximity and that subsequent higher order clustering of the 6-helix bundles facilitates membrane fusion. Melikyan and co-workers (12) arrived at entirely opposite conclusions based on their studies of the timing of fusion pore formation, determined by the flow of a fluorescent dye between the effector and target cell, in relationship to the action of HIV gp41-derived peptides that inhibit bundle formation (C34 or N36). They showed that bundle formation is required for the fusion process, but some (if not all) bundle formation occurs after a pore has formed (30) .
We examined this issue by monitoring the temporal sequence of conformational states of receptor-triggered HIV-1 gp41 using NC-1, a monoclonal antibody (MAb) (25, 31) that has been shown to react with gp41 following the triggering of Env by CD4 and coreceptors (31) . In addition, we used 5-helix, a designed, recombinant protein that consists of three N-helical peptides and two C-helical peptides (18) . This protein binds to the C-helical region of gp41 and potently inhibits the fusogenic activity of gp41 at nanomolar concentrations. A tagged 5-helix protein containing the Myc epitope has been shown to immunopreciptate HIV-1 gp41 following its triggering by HIV-1 receptors (19) .
Using analytical and quantitative video microscopy, we have monitored conformational changes in gp120-gp41 expressed on cells as a function of time following interactions of Env-expressing cells with target cells (32) using a nonspecific probe. In this paper, we have extended these observations using reagents that are specific for the different conformations of triggered HIV-1 gp41. Our results shed some light on conformations of gp41 trimer that may be targets for neutralization. , and N35 CCG -N13 were prepared as described (15) (16) (17) . The peptide C34, derived from HIV-1 Env (10), was synthesized by SynPep (Dublin, CA). Immunofluorescence. The Env-expressing HeLa or CHO-WT were previously stained with the cytoplasmic dye CellTracker Blue CMAC (7-amino-4-chloromethylcoumarin) (Molecular Probes, Inc., Eugene, OR). SupT1 cells were loaded with calcein AM (Molecular Probes, Inc., Eugene, OR), which is cleaved inside the cell by nonspecific esterases, and the colorless calcein AM is converted to fluorescent calcein green. To observe binding of the NC-1 MAb or 5-helix, the Env-expressing cells were plated at the bottom of 35 mm wells (P35Gcol-0-10-C, MatTek Corporation, Ashland, MA) and incubated with target cells at 37°C and 5% CO 2 for a desired time in the range of 0-30 min. After timed incubation, the cells were immediately placed on ice to stop the fusion processes. Cells were washed twice with ice-cold washing buffer (D-PBS with calcium and magnesium, Quality Biological, Inc., number 114-059-101, containing 0.1% bovine serum albumin and 0.02% sodium azide). Nonspecific Fab binding was blocked with blocking solution (2% normal goat serum in D-PBS) containing 1 µg/mL unconjugated goat anti-mouse Fab for 30 min on ice. Then, the cells were washed twice with the washing buffer, once with 2% goat serum, and incubated in 2% goat serum blocking solution supplemented with 1 µg/mL of the NC-1 MAb. Incubation continued for 1 h on ice. The cells were then washed twice with washing buffer, once with blocking solution, and incubated with 1 µg/mL Cy5 conjugated goat anti-mouse Fab in blocking solution. Incubation with the secondary antibody continued for 1 h on ice. The cells were washed 3 times and covered with 1 mL/well washing buffer prior to microscopic observation. To detect the interaction with 5-helix, we had one more step in the immunostaining procedure, i.e., after the initial blocking the cells were incubated with 5-helix for 1 h on ice. Then, the procedure continued by incubating with the primary 9E10 MAb and Cy5-conjugated goat anti-mouse Fab as described above. Cell fusion was monitored using a dye redistribution assay as described previously (35) .
EXPERIMENTAL PROCEDURES
Microscopy. Quantitation of gp41 Epitope Exposure. The stacked images were processed by using the MetaMorph 4.0 software to quantify the relative presence of different conformations of gp41 on the cells by measuring the fluorescent intensity of Cy5 dye, which was covalently bound to the secondary anti-mouse polyclonal fragment antibody. The target cells were added to the plated Env-expressing cells. Stacks of four successive images were collected in the same field using different filter cubes and microscope modes: differential interferometry contrast image, blue fluorescence image for the Env-expressing cells, green fluorescence image for the target cells with eventual fusion events, and red fluorescence image for the Cy5-staining monitoring the gp41 conformational changes. We used two different approaches to quantify the amount of triggered gp41, both on the basis of quantification of the binding of the Cy5-conjugated Fab, which is assumed to be proportional to the amount of the triggered gp41. When the Env expression was relatively high, the fluorescence was spread all over the cell membrane. In this case, we placed a threshold on the blue image showing the area occupied by the Env-expressing cells stained with CMAC, marked this area in regions, switched the stack image to the red one (Cy5), and integrated both the area and the fluorescence intensity within the regions. The ratio between integrated fluorescence intensity and total region area, i.e., intensity per unit cell area, was used as a relative measure for the number of gp41 molecules that have undergone conformational changes. When the Env expression was not very high, aggregates of gp41 molecules were visualized as fluorescent dots on the cell membranes. Even though the number of gp41 molecules in these fluorescent "islands" is not known, we assumed that the number of fluorescent islands is proportional to the number of triggered gp41 molecules. We subtracted the background intensity level and enhanced the contrast by cutting out high-intensity levels. Thus, the resultant image represents a black panel with white dots, which are visualized as aggregates of triggered gp41 molecules. We counted the number of these white dots and divided by the number of the Env-expressing cells.
For a better representation of the immunofluorescence results, we normalized almost all obtained antibody-binding data by using the following equation: B ) (I -I min )/(I max -I min ), where B is the extent of binding plotted on the graph, I is the measured fluorescence for a graph point, and I max and I min are the respective maximum and minimum fluorescence, respectively, obtained in that experimental set.
Western Blotting. Proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on premade 10-20% linear-gradient nonreducing Tris-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine (Tricine) gels (Invitrogen, Carlsbad, CA) as described (17) . The gels were soaked for 10 min and then transferred onto a nitrocellulose membrane (Schleicher and Schuell, Keene, NH) in 25 mM Tris buffer at pH 8, 190 mM glycine, and 20% methanol using a mini-electrophoretic transfer apparatus (Bio-Rad, Hercules, CA). The blots were then processed using a Western Breeze kit, a chromogenic immunogenic system for the detection of rabbit secondary antibodies (Invitrogen, Carlsbad, CA).
RESULTS
To probe conformational changes in gp41, we used the NC-1 MAb, which was generated by immunizing mice with the minimal ectodomain of gp41, comprising the polypeptide N36(L6)C34 that forms 100% 6-helix bundle in physiological solution (31) . Figure 1 displays the results of Western blot analysis with the NC-1 MAb and polyclonal anti-C34 sera. The antibodies were probed against four protein and peptide Figure  1C displays the results of Western blot analysis against polyclonal anti-C34 serum. A weak band is evident for N CCG -gp41, as expected because this comprises the 6-helix bundle, which includes the C-helical region, as well as the exposed trimeric coiled-coil of N-helices stabilized by intermolecular disulfide bonds. Bands at the position of monomeric C34 are also seen in the N35 CCG -N13 sample with 6% C34 present (lane 2) and the pure C34 sample (lane 4). No evidence for the presence of C34 is seen in the N35 CCG -N13 sample in lane 3. Because the NC-1 MAb was raised against the minimal ectodomain core of gp41 in which the N-and C-helical regions were linked by a 6-residue linker sequence and because the NC-1 MAb clearly recognizes specifically the trimeric form of N35 CCG -N13 (with no C34 present), it follows that the NC-1 MAb is directed against the surface of the N-helices that is exposed between the Chelices in the 6-helix bundle. As seen in Figure 2 , the Nhelices comprise a relatively wide and shallow groove along the entire length of the 6-helix bundle.
Using this information, we monitored conformational changes in gp120-gp41 expressed on cells by immunofluorescence following the interactions with CD4 and coreceptors on the target cells. After different times of coculture at 37°C of HeLa cells expressing HIV-1 LAI Env with SupT1 cells, the mixture was cooled to 4°C and immunoassayed with the NC-1 MAb. Images were examined in differential interference contrast (top panels of Figure 3 ) and in fluorescence for Cy5 staining to measure the NC-1 MAb binding (bottom panels of Figure 3) . At zero time, only a few Cy5-stained cells were seen. However, there was a marked increase in the number of Cy5-stained cells after 10 and 15 min of incubation with SupT1 cells. After 20 min of coculture on the other hand, the number of Cy5-stained cells had markedly decreased, indicating that the NC-1 MAb binding was reduced as a result of more prolonged interactions between Env-expressing cells and target cells. Because the immunostaining procedure involves cooling to 4°C, followed by washing off the SupT1 cells before addition of antibodies, we were not able to determine whether the Cy5 staining does appear at the contact region between target and Env-expressing cells. However, the transient interactions between Env-expressing and target cells at 37°C leave an imprimatur on the Env-expressing cells, which is revealed by staining with the conformation-specific NC-1 MAb. Figure 3B illustrates the labeling pattern in the course of fusion between HeLa cells expressing high levels of Env FIGURE 2: Molecular surface of the HIV-1 6-helix bundle. The image is based on the crystal structure of (N36/C34) 3 in the heterotrimeric coiled-coil conformation (10) (PDB 1AIK). The internal N-helices (N36, residues 546-579) are colored in blue, while the external C-helices (C34, residues 628-661) are shown in red. Note that a significant portion of the N-helices, constituting a relatively wide and shallow groove along the length of the ectodomain core, is surface-accessible. and SupT1 cells that were preloaded with the aqueous dye calcein. The figure shows that the calcein is confined in SupT1 cells at 10 min of incubation but redistributes to HeLa cells after 30 min, indicating the appearance of fusion. NC-1 staining, which can be seen 10 min after binding to the target cells, significantly decreases after 30 min.
The above result shows the transient appearance of gp41 conformational intermediates in the fusion process. To examine the kinetics of conformational changes in gp120-gp41 expressed on cells as a function of time following interactions of Env-expressing cells with target cells, we processed the images such as those shown in Figure 3 using the MetaMorph 4.0 software. The relative presence of different conformations of gp41 on the cells was quantified by measuring the fluorescent intensity of the Cy5 dye. HeLa cells expressing HIV-1 LAI Env were incubated with SupT1 cells that were preloaded with the aqueous dye calcein. After different times of coculture at 37°C, the mixture was cooled to 4°C and examined for calcein staining of the HeLa cells to detect cell-cell fusion and for Cy5 staining to measure NC-1 MAb binding. Figure 4 shows that there was a marked increase in intensity of Cy5 fluorescence in HeLa cells after 10 min of incubation with SupT1 cells in the absence of dye redistribution, i.e., before fusion occurs. Binding of the NC-1 MAb reached a maximum value after 15 min and then declined to the background after about 30 min when fusion started to take off. The fact that the NC-1 MAb binds trimeric N35 CCG -N13 (see Figure 1) indicates the appearance by immunostaining (Figures 3 and 4) of an N-terminal trimeric gp41 prehairpin intermediate, which occurs significantly prior to 6-helix bundle formation.
Because previous studies indicate that the prehairpin can be triggered by CD4 alone (6, 12, 22) , we examined the time course of conformational changes induced by cells expressing CD4. For these experiments, we used NIH3T3 cells that have been engineered to express equal levels of cell surface CD4 as NIH3T3 cells, which express both CD4 and CXCR4. As shown in Figure 5 , the kinetics of NC-1 MAb binding to HIV-1 LAI Env-expressing cells following incubation with NIH3T3CD4 exhibits a pattern similar to that following incubation with NIH3T3CD4CXCR4. These data confirm that the conformational changes seen by the NC-1 MAb are for the most part triggered by CD4. These conformational changes do not lead to fusion because no dye redistribution is seen when the Env-expressing cells are incubated with cells expressing only CD4. The conformational changes triggered by both CD4 and CXCR4, on the other hand, lead to fusion. In relation to the profile of NC-1 binding to Envexpressing cells with time, the greatest NC-1 binding is observed early in the fusion event (Figure 3) . Because the amount of 6-helix bundle formation required for fusion is presumed to be minor at this early stage (1) and likely undetectable by probing with NC-1, it follows that NC-1 binding observed at this point is directed toward the prehairpin intermediate on the cell surface. Furthermore, the decline in NC-1 binding as cell-cell fusion proceeds suggests that any existing 6-helix bundle occurring at the contact region between cells is inaccessible to NC-1.
What then is the nature of gp41 molecules whose detection by the NC-1 MAb rapidly declines after 10-15 min of incubation of Env-expressing cells with target cells? To further examine the kinetics of these conformational changes, we used the tagged 5-helix protein containing the Myc epitope. This molecule binds to free C34 and inhibits HIV-1 Env-mediated fusion at nanomolar concentrations (18, 19) . Moreover, C34 inhibits the fusion inhibitory activity of 5-helix. Hence, 5-helix interacts with the gp41 C-helical regions when they are not in contact with the N-helical regions as in the case of the prehairpin intermediate. In the 6-helix bundle, these two regions interact, and hence, the C-helical region is not accessible to 5-helix. Figure 6 shows that binding of 5-helix to HIV-1 Env-expressing cells increases steadily as a function of time, even when . The cells were then supplemented with DMEM-2 and incubated for 5 h at 37°C and 5% CO 2 to express the Env. After the IIIB Env was expressed, the cells were overlaid by NIH3T3CD4 or NIH3T3CD4CXCR4 previously lifted off by using PBS-based cell dissociation buffer (Invitrogen Corp., Carlsbad, CA). The ratio between the overlaid and plated Env-expressing cells was 1:1. The appearance of NC-1 MAb binding and fusion was quantified at different time points as described in the Experimental Procedures for quantification of relatively high Env expression. Smoothed curves passing through the data points of the graphs were generated by a cubic spline interpolation using SigmaPlot (SPSS, Inc., Chicago, IL).
fusion takes off, indicating that some form of gp41 that is not detected by the NC-1 MAb still remains on the cell surface at later times.
We hypothesize that the decline in NC-1 MAb binding and increase in 5-helix binding is due to the dissociation of prehairpin trimers into gp41 monomers (11, 16, 36) . To test this hypothesis, we used the peptide N36
Mut(e,g)
, which was designed to completely abolish any N-helical binding to the C-helical region while maintaining the ability to self-associate into well-defined trimers (16) . N36 Mut(e,g) is assumed to inhibit HIV Env-mediated fusion by shifting the trimeric forms of the gp41 prehairpin to monomeric forms of membrane-bound gp41 (16) . In accordance with this hypothesis, we find that, in the presence of N36 Mut(e,g) , binding of 5-helix is significantly enhanced in comparison to the binding of the NC-1 MAb (Figure 7) . Because the immunostaining procedure involves cooling to 4°C, followed by 2-fold washing with ice-cold buffer before the addition of antibodies, the bound N36 Mut(e,g) molecules are most likely dissociated from the heterotrimer by the time binding with the NC-1 MAb or 5-helix is enabled. Therefore, binding of the NC-1 MAb to possible gp41-N36 Mut(e,g) heterotrimers is unlikely to be observed, and the predominant gp41 form detected on the cell surface by 5-helix represents gp41 monomers.
As a control for the N 36Mut(e,g) experiment, we further examined the binding of the NC-1 MAb to triggered gp41 in the presence of C34, which potently inhibits fusion by binding to the N-helical trimer in the prehairpin intermediate state, thus preventing 6-helix bundle formation (37) . Figure  8 shows that at low concentrations of C34 the NC-1 MAb binding increases with time, consistent with the notion that the N-helical trimer/C34 complex preserves the topology of the prehairpin intermediate, which is accessible for NC-1 MAb binding. Because the binding site for C34 is in the groove formed by the N-helical trimer (37) and is known to inhibit fusion at low nanomolar concnentrations, it presumably binds more tightly to the prehairpin and is not removed by the washing procedure. However, surprisingly, at a concentration of 100 nM C34, NC-1 MAb binding is significantly reduced.
DISCUSSION
In this paper, we have addressed questions regarding mechanisms of HIV entry and its inhibition. One question is related to the timing and nature of the conformational changes in HIV-1 gp41 that lead to fusion. In doing so, we had to reevaluate the specificity of the gp41 and NC-1 MAb, which was raised against the 6-helix bundle (31) . Because the NC-1 MAb does not bind to N and C peptides but recognizes N-peptide/C-peptide mixtures (31, 38, 39) and binds to the 6-helix bundle formed by N36(L6)C34 but not to domains with mutations in N-and C-helical regions that disrupt the 6-helix bundle formation (31) , it has been assumed that the NC-1 MAb uniquely binds to the 6-helix bundle. However, on the basis of the data shown in Figure  1 , it is clear that the NC-1 MAb binds to N-helical trimers as well as the 6-helix bundle and not to monomers. We have used the ability of the NC-1 MAb to detect N-helical trimers to monitor conformational changes in gp41 as the reaction proceeds. The generally accepted model for HIV-1 Env-mediated fusion is diagrammed in Figure 9 . Triggering the HIV-1 envelope glycoprotein trimer (E 3 ) by clusters of CD4 on the target membrane (T′) results in a conformational intermediate (E 3 ′) that exposes the coreceptor-binding site on gp120 and forms the gp41 prehairpin intermediate. This event is followed by the engagement of gp120 with clusters of coreceptors on the target membrane (T′′), which results in the formation of the gp41 6-helix bundles (E 3 ′′) that drive the fusion (1, 5, 7) . Presumably, the NC-1 MAb cannot bind in the areas of contact between Env-expressing and target membranes (E 3 ′T′, E 3 ′T′′, and E 3 ′′T′′). However, the transient interactions between Env-expressing effector cells and target cells leaves the conformationally altered Env (E 3 ′) exposed, which is available for NC-1 MAb binding (Figures 3-5) . The similar kinetics of Env triggering exhibited by NIH3T-3CD4 and NIH3T3CD4CXCR4 ( Figure 5) is consistent with the model. It appears that only a few 6-helix bundles are required for fusion (1) . Therefore, the slight increase in potential NC-1 MAb binding sites (in the form of 6-helix bundle) triggered by CD4 and CXCR4 will not contribute to the overall signal. Moreover, these 6-helix bundle binding sites reside in the contact region between cells and are therefore unlikely to be accessible to the NC-1 MAb, which has no detectable inhibitory activity for HIV-1 infection or fusion (31) . Because binding to E′ 3 alone should not affect the fusion reaction, the model also explains why a MAb that binds well to Env is incapable of neutralization (40) . The decrease in NC-1 MAb staining after it reaches a peak value at 10-15 min is presumed to be the result of formation of gp41 monomers (E′), a process that is accelerated in the presence of certain entry inhibitors. The time course of NC-1 MAb staining is very similar to that shown by Finnegan et al. (25) using anti-gp41 cluster I and II MAbs.
We surmise that the NC-1 MAb does not inhibit HIV-1 fusion because it has limited access to the contact region between viral and target membranes, although it binds well to the gp41 prehairpin intermediate once the target cells are removed. The notion that the gp41 prehairpin trimer has limited access in the contact region is consistent with a recent study (41) showing that C-terminal peptides attached to cargo proteins of various sizes progressively lose inhibitory potency with increasing cargo size, although they bind with equal potency to a gp41 N-helical trimer construct. On the other hand, certain MAbs directed toward the gp41 membrane proximal external region exhibit broadly neutralizing activity (42) . A structural study of the MAb 2F5 bound to its peptide suggests a possible mechanistic explanation for the neutralizing activity of this MAb (43) . They discovered a long complementarity determining region loop on the antibody with a hydrophobic patch of amino acids at the end of this loop, which interacts with both the target peptide and adjacent viral membrane. The particular structure of this class of MAb's may therefore allow accessibility of the MAb to its target site even in the contact region between the virus and cell.
Most studies on the mechanism of HIV fusion have focused on the triggered conformational changes in Env, which eventually result in the formation of gp41 6-helix bundles that drive the fusion between HIV and target membranes (12, 22) . The pathway (Figure 9 ) that involves the dissociation of prehairpin trimers (E 3 ′) to gp41 monomers (E′) had originally been proposed by Clore and co-workers (11) to account for the mode of action of certain peptidic entry inhibitors. Several peptides that mimic the sequence of the C-and N-helical regions of HIV-1 have been found to inhibit fusion either by blocking the interaction between the N-and C-helical regions (37, 44) or by promoting the dissociation of gp41 trimers into monomers and thus preventing the formation of the 6-helix bundle fusogenic state of gp41 (16) . C-helical-derived peptides such as C34 inhibit HIV-1 Env-mediated cell fusion in the nanomolar range, through binding to the hydrophobic grooves that line the internal N-terminal trimeric coiled-coil core of the gp41 ectodomain (37) . N-helical-derived peptides such as N36 are much less effective inhibitors with IC 50 values in the micromolar range (13) . To examine the mode of action of this class of peptides, Bewley et al. (16) designed a multisite mutant known as N36 Mut(e,g) , which completely abolishes any N-helical peptide binding to the C-helical region while maintaining the ability to self-associate into well-defined trimers. N36 Mut(e,g) forms a monodisperse, helical trimer in solution, does not interact with C34, and yet inhibits fusion about 50-fold more effectively than the parent N36 peptide (16) . Because N36 Mut(e,g) forms a well-defined trimeric species that does not interact with either C34 or the chimeric protein N CCG -gp41 (in which the N-helices of the solvent-exposed trimeric coil-coil are covalently linked by interhelical disulfide bonds), it must target the N-helical region of the prehairpin intermediate by forming fusion-incompetent heterotrimers (16) . The fusion-inhibitory activity of N36 Mut(e,g) therefore indicates the presence of a dynamic equilibrium between monomeric, dimeric, and trimeric forms of membrane-bound gp41 that allows subunit exchange to take place in the prehairpin intermediate state. The rate of exchange between these species must be sufficiently fast to permit efficient heterotrimer formation within the lifetime (∼15 min) of the prehairpin intermediate (16) . An analysis of the inhibition of HIV Env-mediated cell fusion by N36 Mut(e,g) indicates that, at saturating concentrations of N36 Mut(e,g) , the predominant species is a heterotrimer consisting of one gp41 prehairpin and two N36 Mut(e,g) molecules (16) .
The fact that the NC-1 MAb binds to trimeric and not monomeric gp41 provided us with an opportunity to monitor FIGURE 9: Model of intermediates during HIV-1 Env-mediated fusion. The interactions of HIV-1 Env trimers (E 3 ) with CD4 clusters (T′) induce conformational changes that result in the exposure of the binding site on gp120 that can engage CXCR4 and the exposure of the gp41 prehairpin trimer (E 3 ′) in an Envtarget membrane complex (E 3 ′T′). This is followed by engagement of CXCR4 clusters (T′′) to form an E 3 ′T′′ complex that results in 6-helix bundle formation (E 3 ′′) and fusion. In a parallel reaction, Env-target complexes dissociate to expose triggered Env (E 3 ′) on the surface, which is susceptible to NC-1 MAb binding. The triggered Env trimer (E 3 ′) can then dissociate to gp41 monomers, a process that is enhanced by entry inhibitors such as N36 Mut(e,g) . See the text for further explanation.
gp41 trimer-monomer transitions following the triggering of HIV-1 Env. The enhanced formation of monomer gp41 and decreased formation of trimer observed when the Envexpressing cells were being incubated with target CD4 and coreceptor-expressing cells in the presence of N36 Mut(e,g) ( Figure 7) is consistent with the notion that N36 Mut(e,g) inhibits by shifting the equilibrium of the prehairpin intermediate to a heteromeric state, which eventually results in the appearance of gp41 monomers. On the other hand, a low concentration (10 nM) of C34 appears to prolong NC-1 MAb binding to triggered Env (Figure 8) , consistent with the notion that C34 binds to the N-terminal internal trimeric coiledcoil to form a peptide/protein hybrid structure (44) . At higher C34 concentrations (100 nM), we do observe a decrease in NC-1 MAb binding (Figure 8 ), indicating that there is lowaffinity binding of C34 to the gp41 monomer (36) ; at high C34 concentrations, the reaction could then be driven toward the gp41 monomeric state. An alternative explanation for this observation could be that C34 slows down the formation of the gp41 prebundles in a dose-dependent manner, leading to apparent reduction in NC-1 binding within the first 30 min at 37°C.
We further studied conformational changes in Env using the 5-helix protein (18, 19) , which lacks a third C-helix peptide, and this vacancy is expected to create a high-affinity binding site for the C-helical region of gp41. This protein binds the C-peptide region of gp41 and potently inhibits the fusogenic activity of gp41 at nanomolar concentrations. Although 5-helix binds to native gp41 (45) , it binds strongly to gp41 activated by the interaction of the envelope protein with either soluble CD4 or membrane-bound cellular receptors (19) . Because 5-helix cannot bind to 6-helix bundles, we would expect 5-helix binding to decrease if there was only a prehairpin-trimer to 6-helix bundle conversion during the fusion reaction. In contrast, we observe a steady increase in the binding of 5-helix to HIV-1 Env-expressing cells (Figures 6 and 7) under conditions where NC-1 MAb binding decreases. This indicates a parallel pathway that involves the generation of gp41 monomers coexisting with the trimers during the fusion reaction ( Figure 9 ). The formation of heterotrimers consisting of gp41 and N36 Mut(e,g) results in a shift of the reaction pathway towards gp41 monomers following dissociation of the peptide from the heterotrimer. This pathway may deserve some consideration in the design of entry inhibitors and vaccine candidates.
